Ophthalmological features of Parkinson disease

Safranow, Krzysztof·2014·Medical Science Monitor
DOI 10.12659/msm.890861

Cited by (119)

Items 101–119 of 119

  1. New insights in non-motor symptoms in Parkinson’s disease
    Cristian Falup‐Pecurariu, Alessandra Fanciulli, Rupam Borgohain, К. Ray Chaudhuri, Vinod Metta · 2024 · Frontiers research topics
  2. Video-based Analysis of the Blink Reflex in Parkinson’s Disease Patients
    Talisa S. Jansen, Gökhan Güney, Bergita Ganse, Mariana H.G. Monje, Jörg Bernhard Schulz, Manuel Dafotakis, Christoph Hoog Antink, Anne Kristin Braczynski · 2023 · Research Square
  3. Trockenes Auge — unterschätzt und unterdiagnostiziert
    Ilona Csóti, Paul Lingor · 2018 · NeuroTransmitter
  4. Visual Functions in Parkinson’s Disease
    Mosaad Alhassan · 2018 · UWSpace (University of Waterloo)
  5. Disturbances of visual perception in non-demented patients with Parkinson’s disease
    R. Timofejavaitė, V. Vilda, A LIVEIKIENE, Rūta Kaladytė Lokominienė · 2019 · Neurologijos seminarai
  6. VISUAL DISTURBANCES IN PARKINSON’S DISEASE PATIENTS
    Nicoleta Tohănean, Lucia N. Muntean, Horea Demea, Lăcrămioara Perju‐Dumbravă · 2015 · Romanian Journal of Neurology
  7. Cataract surgery utilization in Parkinson’s disease: the english longitudinal survey on ageing
    Angela L. Xu, Ali G. Hamedani · 2023 · Graefe s Archive for Clinical and Experimental Ophthalmology
  8. Effect of dopaminergic therapy on lacrimation in Parkinson's disease
    Anna A. Pilipovich, Vorob'eva Ov, S. A. Makarov, Кучук Андрей Владимирович · 2023 · Neurology neuropsychiatry Psychosomatics
  9. Synsvansker ved Parkinsons sykdom
    Solveig E J Dalbro, Emı́lia Kerty · 2024 · Tidsskrift for Den norske legeforening
  10. Analyse von Tränenflüssigkeit als Biomarkerquelle beim idiopathischen Parkinsonsyndrom
    Hannah Linda Jane Paul · 2024
  11. Features of the use of tear substitutes, depending on the release form, in the treatment of dry eye disease in patients with Parkinson’s disease
    Kateryna Yu. Hrizhymalska, I. V. Komarovska, T.Yu. Kukuruza · 2024 · Archive of Ophthalmology and Maxillofacial Surgery of Ukraine
  12. Total meibomian gland loss in Parkinson’s disease
    Prajakta Dandekar, Swati Singh · 2025 · Orbit
  13. IMMUNE "OCULAR SURFACE PROPERTIES AND RESPONSE IN PARKINSON'S DISEASE PATIENTS UNDERGOING AND NOT UNDERGOING TREATMENT"
    2024 · MINAR International Journal of Applied Sciences and Technology
  14. A genetic perspective on retinal thinning in Parkinson's disease: Direct damage or comorbid glaucoma?
    Mengyue Xu, Mengqi Qin · 2025 · Parkinsonism & Related Disorders
  15. Cataracts as a potential non-motor marker for Parkinson's disease: An observational study based on UK biobank data
    Yu Fan, Zhen Jie Hu, Jing-jin Wan, Yi-ren Yang, Sijia Huang, Fangzheng Chen, Min Zhong, Xinyi Zhou, Jun Liu, Yuanyuan Li · 2025 · NeuroMarkers.
  16. Systemic Conditions Associated With Blepharitis: A Case–Control Study
    Noa Kapelushnik, Lital Smadar, Inbal Goldshtein, Ari Leshno, Lee Nussbaum, Guy J. Ben-Simon, Daphna Landau · 2025 · Cornea
  17. Color Vision Deficits and Eye Movement Abnormalities in Parkinson’s Disease
    Julia Mleczek, Anim Forjindam, Aasef G. Shaikh, Fatema F. Ghasia · 2026 · Contemporary clinical neuroscience
  18. Comparative study of refractive errors between patients with Parkinson’s disease versus age- and sex-matched healthy controls
    Ali Shoeibi, Reyhaneh Shariati-Moghaddam, Morad Amir Ahmad, Hadi Ostadimoghaddam, Hassan Hashemi, Akbar Derakhshan, Zahra Hemmatian, Abbasali Yekta, Mehdi Khabazkhoob · 2026 · BMC Neurology
  19. Beyond motor recovery: subthalamic nucleus deep brain stimulation may improve blinking and dry eye symptoms without restoring tear film homeostasis in Parkinson’s disease
    Ebru Cömert Hamzaoglu, Vural Hamzaoğlu, Uzay ATEŞ, Ayten Yüksek, Orhan Beğer, Emin Serbülent Güçlü · 2026 · BMC Ophthalmology